We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Australia Issues Guidance on Minor Biologic, Chemical Variations
Australia Issues Guidance on Minor Biologic, Chemical Variations
June 12, 2013
On May 22, Australia’s Therapeutic Goods Administration introduced revisions to administrative processes when drugmakers make minor variations to prescription drugs.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor